Ann: Definitive Supply Agreement Executed with HL Pharma, page-147

I could accept that dropping one distributor for two new ones would probably be seen as an 'upgrade' in MGC's potential future revenue streams. However that would only apply if there was no delay between the voiding of HL Pharma deal (if this has occurred) and the signing of these two new Australian distributor agreements. If there was any gap in time between the transition and it was not announced during that transitional period where no Australian distributor was lined up, they would be in breach of their obligations IMO.